Rosenkranz B, Ledermann H, Frölich J C
J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):943-9. doi: 10.1097/00005344-198609000-00010.
The cardiovascular effects of single oral doses of nifedipine (20 mg), atenolol (50 mg), or of their combination were compared with placebo in a double-blind randomized cross-over study in 10 normotensive volunteers. After subjects rested for 2 h, before drug administration, heart rate, blood pressure, stroke volume index, and cardiac index were measured noninvasively. These cardiovascular parameters were then determined prior to and after exercise periods (160 W, 10 min, bicycle ergometry) which were performed 40, 70, 130, 190, 310 min, and 22 h after drug intake. Nifedipine decreased resting diastolic blood pressure (p less than or equal to 0.05) after 2 h, whereas systolic blood pressure remained unchanged and heart rate significantly increased at rest and after exercise. Stroke volume index and cardiac index were unaffected. Atenolol significantly decreased systolic and diastolic blood pressure as well as heart rate; stroke volume index following exercise increased significantly, and cardiac index was unchanged. Administration of the combination caused a significantly more pronounced fall of systolic and diastolic blood pressure as compared with either drug alone, whereas the negative chronotropic effect was not different from that of atenolol. As did atenolol, the combination increased stroke volume index after exercise with no change in cardiac index. Maximum plasma concentrations of nifedipine (37.1 +/- 16.7 ng/ml) and atenolol (276.3 +/- 107.2 ng/ml) and terminal half-life of atenolol (9.9 +/- 2.6 h) were not altered by combined administration of the drugs.
在一项双盲随机交叉研究中,对10名血压正常的志愿者口服单剂量硝苯地平(20毫克)、阿替洛尔(50毫克)或二者联合用药后的心血管效应与安慰剂进行了比较。在受试者休息2小时后、给药前,采用无创方法测量心率、血压、每搏量指数和心脏指数。然后在服药后40、70、130、190、310分钟和22小时进行运动期(160瓦,10分钟,自行车测力计)前后测定这些心血管参数。硝苯地平在2小时后使静息舒张压降低(p≤0.05),而收缩压保持不变,静息和运动后心率显著增加。每搏量指数和心脏指数未受影响。阿替洛尔显著降低收缩压和舒张压以及心率;运动后的每搏量指数显著增加,心脏指数未变。联合用药导致收缩压和舒张压的下降比单独使用任一药物都更显著,而负性变时作用与阿替洛尔无差异。与阿替洛尔一样,联合用药在运动后增加了每搏量指数,心脏指数无变化。联合给药未改变硝苯地平的最大血浆浓度(37.1±16.7纳克/毫升)、阿替洛尔的最大血浆浓度(276.3±107.2纳克/毫升)以及阿替洛尔的终末半衰期(9.9±2.6小时)。